0001387131-19-001528.txt : 20190227 0001387131-19-001528.hdr.sgml : 20190227 20190227172904 ACCESSION NUMBER: 0001387131-19-001528 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190226 FILED AS OF DATE: 20190227 DATE AS OF CHANGE: 20190227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEDERMAN SETH CENTRAL INDEX KEY: 0001563420 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36019 FILM NUMBER: 19639058 MAIL ADDRESS: STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP STREET 2: 509 MADISON AVE., SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp. CENTRAL INDEX KEY: 0001430306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261434750 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 509 MADISON AVE. - SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 1-800-849-7894 MAIL ADDRESS: STREET 1: 509 MADISON AVE. - SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC. DATE OF NAME CHANGE: 20080320 4 1 ownership.xml X0306 4 2019-02-26 0 0001430306 Tonix Pharmaceuticals Holding Corp. TNXP 0001563420 LEDERMAN SETH C/O TONIX PHARMACEUTICALS HOLDING CORP. 509 MADISON AVE., SUITE 306 NEW YORK NY 10022 1 1 0 0 Chief Executive Officer Stock Option 1.89 2019-02-26 4 A 0 23265 0.00 A 2020-02-26 2029-02-25 Common Stock 23265 23265 D Stock Option 2.36 2019-02-26 4 A 0 23265 0.00 A 2020-02-26 2029-02-25 Common Stock 23265 23265 D The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months. The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan. /s/ Seth Lederman 2019-02-27